PL407771A1 - Wound dressing, preferably for treatment of haemorrhoidal disease and method for producing it - Google Patents

Wound dressing, preferably for treatment of haemorrhoidal disease and method for producing it

Info

Publication number
PL407771A1
PL407771A1 PL407771A PL40777114A PL407771A1 PL 407771 A1 PL407771 A1 PL 407771A1 PL 407771 A PL407771 A PL 407771A PL 40777114 A PL40777114 A PL 40777114A PL 407771 A1 PL407771 A1 PL 407771A1
Authority
PL
Poland
Prior art keywords
matrix
hydrochloride
wound dressing
bionanocellulose
dressing
Prior art date
Application number
PL407771A
Other languages
Polish (pl)
Other versions
PL226332B1 (en
Inventor
Magdalena Kukowska-Kaszuba
Dariusz Bobiński
Waldemar Wilandt
Original Assignee
Bowil Biotech Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bowil Biotech Spółka Z Ograniczoną Odpowiedzialnością filed Critical Bowil Biotech Spółka Z Ograniczoną Odpowiedzialnością
Priority to PL407771A priority Critical patent/PL226332B1/en
Publication of PL407771A1 publication Critical patent/PL407771A1/en
Publication of PL226332B1 publication Critical patent/PL226332B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Przedmiotem wynalazku jest opatrunek na rany, zwłaszcza do leczenia choroby hemoroidalnej, zawierający matrycę z bionanocelulozy i środek biologicznie czynny analgetyczny w postaci chlorowodorku charakteryzujący się tym, że materiał matrycy opatrunku stanowi bionanoceluloza o zmodyfikowanych właściwościach strukturalnych polimeru i wybrane środki analgetyczne w postaci chlorowodorku, korzystnie chlorowodorek bupiwakainy, przy czym matryca bionanocelulozowa ma kształt w przekroju wzdłużnym zbliżony do litery T lub I lub zbliżony do figury geometrycznej, korzystnie prostokąta lub kwadratu a chlorowodorek środka analgetycznego jest naniesiony na matrycę lub do zbiorniczka zestawionego z matrycą. Ujawniono także sposób wytwarzania opatrunku na rany. W szczególności wynalazek dotyczy opatrunku wykazującego działanie przedłużone, przeznaczonego do zwalczania dolegliwości bólowych chorób proktologicznych.The invention relates to a wound dressing, particularly for the treatment of hemorrhoidal disease, comprising a bionanocellulose matrix and a biologically active analgesic agent in the form of a hydrochloride. The dressing matrix comprises bionanocellulose with modified polymer structural properties and selected analgesic agents in the form of a hydrochloride, preferably bupivacaine hydrochloride. The bionanocellulose matrix has a longitudinal cross-sectional shape similar to the letter T or I, or similar to a geometric figure, preferably a rectangle or square, and the analgesic agent hydrochloride is deposited on the matrix or in a reservoir attached to the matrix. A method for manufacturing the wound dressing is also disclosed. In particular, the invention relates to a dressing with a prolonged effect intended to combat pain associated with proctological conditions.

PL407771A 2014-04-01 2014-04-01 Wound dressing, especially for the treatment of wounds of hemorrhoidal disease and the method of its production PL226332B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL407771A PL226332B1 (en) 2014-04-01 2014-04-01 Wound dressing, especially for the treatment of wounds of hemorrhoidal disease and the method of its production

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL407771A PL226332B1 (en) 2014-04-01 2014-04-01 Wound dressing, especially for the treatment of wounds of hemorrhoidal disease and the method of its production

Publications (2)

Publication Number Publication Date
PL407771A1 true PL407771A1 (en) 2015-10-12
PL226332B1 PL226332B1 (en) 2017-07-31

Family

ID=54266770

Family Applications (1)

Application Number Title Priority Date Filing Date
PL407771A PL226332B1 (en) 2014-04-01 2014-04-01 Wound dressing, especially for the treatment of wounds of hemorrhoidal disease and the method of its production

Country Status (1)

Country Link
PL (1) PL226332B1 (en)

Also Published As

Publication number Publication date
PL226332B1 (en) 2017-07-31

Similar Documents

Publication Publication Date Title
MX2024010140A (en) NEW METHODS.
SV2018005610A (en) SUBSTITUTED OXOPIRIDINE DERIVATIVES
MX378109B (en) SUSTAINED-RELEASE INJECTABLE COMPOSITION AND METHOD OF USE FOR THE TREATING JOINT INFLAMMATION AND PAIN ASSOCIATED WITH IT.
DOP2015000304A (en) BROMODOMINIUM CRYSTAL INHIBITORS
EP4282479A3 (en) Use of pridopidine to treat depression or anxiety
CL2007001318A1 (en) Use of flibanserin, optionally as a free base, hydrate salt or solvate thereof, to prepare a useful medication in the treatment of sexual desire disorders in women.
CL2015003442A1 (en) Heterocyclic derivatives
MY199027A (en) Method for treating or preventing ophthalmological conditions
CL2015003690A1 (en) Use of pridopidine or a salt thereof to prepare a medication useful in the treatment of huntington's disease.
UY33863A (en) METHODS AND MEDICINES FOR THE TREATMENT OF ALZHEIMER'S DISEASE
MX2017001673A (en) Therapeutic medical compression garment and method.
MX376164B (en) COMPOSITIONS AND METHODS FOR TREATING INSOMNIA.
CL2015002835A1 (en) New pyridine derivatives
LT2945642T (en) FACTOR 1 PROTEIN FOR USE IN THE TREATMENT OR PREVENTION OF DISEASE
MX374944B (en) PYRANOCROMENYL PHENOL DERIVATIVE, AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OF METABOLIC SYNDROME OR INFLAMMATORY DISEASE.
WO2015066302A3 (en) Compositions, methods of use, and methods of treatment
CL2014002847A1 (en) Triazolo derivative compounds, pde10 inhibitors; preparation procedure; use for the treatment and / or prophylaxis of psychotic disorders, schizophrenia, anxiety, drug addiction, parkinson's disease, among others.
CL2012002540A1 (en) Agomelatine Hydrochloride Hydrate; crystalline form; Preparation method; pharmaceutical composition; and its use for the treatment of sleep disorders, stress, anxiety, major depression, cardiovascular diseases, among others.
HN2009003424A (en) (OXAZOLIDINON-5-IL-METIL) -2-TIOFEN-CARBOXAMIDAS REPLACED AND ITS USE IN THE FIELD OF THE SANGUINEA COAGULATION
NI201600070A (en) AUTOTAXIN TETRAYCLIC INHIBITORS
MX2020009532A (en) MODIFIED OLIGONUCLOTIDES FOR USE IN THE TREATMENT OF TAUOPATHIES.
WO2014153385A3 (en) Methods of treating metabolic disorders
AR094241A1 (en) CICLESONIDE FOR THE TREATMENT OF RESPIRATORY ROAD DISEASE IN HORSES
MX2016003293A (en) Methods and compositions for treatment of chlamydial infection and related diseases and disorders.
PT3413870T (en) IGMESIN FOR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE